LUNG Q1 2020 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$72M

Q1 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$9M+31.1% YoY

Gross Profit

$6M65.6% margin

Operating Income

-$6M-70.8% margin

Net Income

-$7M-83.1% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

-16.7%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$209,000

Balance Sheet

Total Assets

$0

Total Liabilities

$0

Stockholders' Equity

$0

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$7M	+31.1%
Gross Profit	$6M	$4M	+30.3%
Operating Income	-$6M	-$5M	-22.9%
Net Income	-$7M	-$6M	-22.5%